This website uses cookies

Read our Privacy policy and Terms of use for more information.

By Ollie Potter | Last updated: January 2026 | 9 min read

Contents

TL;DR

  • The alternative protein sector has attracted over $10 billion in venture funding since 2020. The money is now concentrating in fewer, proven players.

  • Impossible Foods leads plant-based with retail presence in 40,000+ stores. Cultivated meat remains stuck in regulatory limbo outside Singapore.

  • Perfect Day's precision fermentation approach has generated actual revenue at scale, shipping 50+ million servings of animal-free dairy protein.

  • The sector split into winners and losers in 2024-2025. Beyond Meat's stock crashed 95% from peak, while NotCo expanded to 15 countries.

  • Regulatory approval is not the bottleneck. Technology is. FDA cleared cultivated chicken in 2023, but production costs remain 10-100x too high for mass market.

Why Alternative Protein Companies Matter in 2026

Animal agriculture generates 14.5% of global greenhouse gas emissions. Alternative proteins offer a path to feeding 10 billion people without destroying the planet. The sector raised $5 billion in 2021 alone, then crashed as investors realised that making fake meat profitable is harder than making it taste good.

The survivors are now separating from the dead. Plant-based meat sales plateaued in 2024 after years of growth. Cultivated meat remains a science project with no clear path to price parity. But precision fermentation companies are quietly shipping millions of servings and signing deals with Nestlé and Starbucks.

$10B+ invested in alternative protein since 2020. Plant-based meat sales hit $1.4 billion in the US in 2024, but growth stalled at 1% year-over-year. Prices stayed 50-100% above conventional meat.

Summary Table

Company

Founded

HQ

Total Funding

What They Actually Make

Impossible Foods

2011

Redwood City, CA

$2B+

Heme-based plant burgers in 40,000 stores

Upside Foods

2015

Berkeley, CA

$608M

Cultivated chicken (FDA-cleared, not yet commercial)

Perfect Day

2014

Berkeley, CA

$750M

Whey protein from fermentation, in ice cream and protein powder

Eat Just

2011

San Francisco, CA

$740M

Mung bean eggs and cultivated chicken (Singapore only)

NotCo

2015

Santiago, Chile

$445M

AI-designed plant milk, meat, ice cream in 15 countries

Our Pick: Perfect Day

If you're betting on one company, watch Perfect Day. They solved the hardest problem: making money. Their precision fermentation platform produces actual whey protein without cows. It's already in products from Brave Robot ice cream to Modern Kitchen protein powder. They're not promising future breakthroughs. They're shipping 50+ million servings and licensing their technology to CPG giants. While cultivated meat companies burn cash waiting for regulatory miracles, Perfect Day is building a real business.

1. Impossible Foods

The plant-based incumbent with 40,000 retail doors and a profitability problem.

Founded: 2011 | HQ: Redwood City, California | Funding: $2B+

Impossible Foods invented the category, then watched competitors copy the playbook. Their heme-based burger bleeds like beef and fooled early adopters. But the company has never turned a profit despite being in every Burger King and Walmart. They raised $500 million in 2022 at a reported $7 billion valuation, then shelved IPO plans as the market soured on unprofitable food tech.

The company's advantage is scale. They're in 40,000 grocery stores and 40,000 restaurants. Their burger costs $2-3 more than beef, which works at Whole Foods but not at Kroger. Revenue hit $500 million in 2023, but they're still burning $100+ million annually.

CEO Peter McBride (who replaced founder Pat Brown in 2024) is cutting costs and expanding into whole cuts. Watch whether they can reach profitability before the cash runs out. The next funding round will tell you if investors still believe.

2. Upside Foods

First FDA-cleared cultivated meat in America, but still can't sell it at scale.

Founded: 2015 | HQ: Berkeley, California | Funding: $608M

Upside Foods won the regulatory race, then hit the economics wall. FDA cleared their cultivated chicken in June 2023. USDA granted the label in November. They served it at Bar Crenn in San Francisco to massive press coverage. Then nothing. Production costs remain somewhere between $50-200 per pound. Chicken breast at Safeway costs $4.

The company built a 53,000 square foot facility in Emeryville that can theoretically produce 50,000 pounds annually. That's a rounding error in a US market that consumes 100 billion pounds of chicken per year. Investors include Cargill, Tyson, and Temasek, which means the incumbents are hedging but not betting the farm.

Founder Uma Valeti is a cardiologist who grew heart cells in labs before pivoting to chicken nuggets. The technology works. The unit economics don't. Watch whether they announce a major scale-up facility or quietly pivot to licensing their tech to Big Ag.

3. Perfect Day

Precision fermentation that actually ships product and makes revenue.

Founded: 2014 | HQ: Berkeley, California | Funding: $750M

Perfect Day is the quiet winner. They genetically engineer microbes to produce whey protein identical to cow's milk, then ferment it at scale. The result: real dairy protein with 97% lower carbon emissions. They're not selling direct to consumers. They're licensing to brands like Brave Robot, Modern Kitchen, and Natreve.

The company has shipped over 50 million servings. They opened a commercial facility in 2023 that can produce millions of pounds annually. Investors include Temasek, Horizons Ventures, and ADM, the $85 billion food giant. That ADM partnership is the signal: this isn't a science project anymore.

Co-founders Ryan Pandya and Perumal Gandhi met at a biotech conference and quit their jobs to start the company in 2014. They raised $361 million in a 2020 Series C, then another $350 million in debt in 2022. Revenue is private, but they're one of the few alternative protein companies actually selling at commercial scale. Watch for a major CPG acquisition or IPO in 2026-2027.

4. Eat Just

Mung bean eggs in 20,000 stores and cultivated chicken in exactly one country.

Founded: 2011 | HQ: San Francisco, California | Funding: $740M

Eat Just runs two businesses. The first, Just Egg, is a mung bean-based egg replacer in 20,000 US stores. It's the fastest-growing egg brand in America, with retail sales up 40% year-over-year. The second, Good Meat, is cultivated chicken approved for sale only in Singapore. One is a real business. The other is a very expensive bet.

The company raised $200 million in 2021 at a $1.2 billion valuation, then faced questions about its Singapore sales numbers. Bloomberg reported that Good Meat had sold just 3,000 pounds of cultivated chicken in its first two years. The company disputed the figures but didn't provide alternatives.

CEO Josh Tetrick is a former college linebacker who pivoted from education non-profits to food tech. He's charismatic and polarising. The company has been trying to go public via SPAC since 2021, but the deal keeps getting delayed. Just Egg is a legitimate product with real traction. Good Meat is a regulatory and economic question mark. Watch whether they spin off the two businesses or double down on both.

5. NotCo

AI-designed plant foods in 15 countries, with Kraft Heinz as a partner.

Founded: 2015 | HQ: Santiago, Chile | Funding: $445M

NotCo uses AI to reverse-engineer animal products from plants. Their algorithm, Giuseppe, analyses the molecular structure of milk or meat, then finds plant combinations that replicate it. The result: NotMilk, NotBurger, NotIceCream, and NotChicken in 15 countries across Latin America and the US.

The company raised $235 million in a 2021 Series D led by Tiger Global at a $1.5 billion valuation. Investors include Bezos Expeditions, Roger Federer, and Lewis Hamilton. They partnered with Kraft Heinz in 2021 to create The Kraft Heinz Not Company, a joint venture targeting North America.

Revenue hit $100 million in 2023, mostly from Latin America where they're the category leader. US expansion has been slower. Their products cost 20-40% more than dairy, which works in Santiago but not in Omaha. Co-founder Matias Muchnick is a biochemist who started the company after watching his father struggle with diabetes. Watch whether the Kraft Heinz partnership delivers US distribution or fizzles like most corporate innovation theatres.

Want the full picture? We cover a different sector every week with the deals, data, and analysis behind the headlines. Subscribe to The NatureTech Memos for free.

What's Actually Happening in Alternative Protein

The sector is splitting in two. Plant-based is a real category with real sales, but growth stalled in 2024. Early adopters maxed out and mainstream consumers balked at the price premium. Impossible and Beyond are fighting for shelf space while burning cash. The winners will be whoever reaches cost parity first. That's a manufacturing problem, not a science problem.

Cultivated meat is stuck in regulatory and economic purgatory. FDA approval was the easy part. Building bioreactors that can produce chicken at $5 per pound instead of $50 is the hard part. Singapore is the only country where you can legally buy it, and even there, it's a novelty.

The smart money is now on precision fermentation. Perfect Day and companies like Formo (Europe) and Imagindairy (Israel) are producing real animal proteins without animals. They're doing it at costs that could actually compete. This is the Bean Free Chocolate moment for protein: the technology that sounds weird but works better than the original.

Frequently Asked Questions

What is the largest alternative protein company? Impossible Foods is the largest by funding and revenue, with over $2 billion raised and $500 million in annual sales. Beyond Meat is publicly traded but has lost 95% of its value since its 2021 peak, with revenue declining year-over-year as consumer interest waned.

Which alternative protein companies are profitable? Almost none. Perfect Day is the closest, with actual revenue from licensing deals, but they haven't disclosed profitability. The sector raised $5 billion in 2021 expecting rapid growth, then discovered that food is a low-margin, capital-intensive business where brand loyalty is hard to build.

Is cultivated meat legal in the United States? Yes, as of 2023. FDA cleared Upside Foods and Eat Just's cultivated chicken for sale. USDA granted labels. But legal doesn't mean available. Production costs are still 10-100x too high for retail, so you can't actually buy it anywhere except a handful of restaurants doing PR stunts.

What is precision fermentation in alternative protein? Precision fermentation uses genetically engineered microbes to produce specific proteins. Perfect Day ferments yeast to make whey. The result is molecularly identical to animal protein, but produced in steel tanks instead of cows. It's the same process used to make insulin, just applied to food.

Why did Beyond Meat stock crash? Beyond Meat went public at $25 in 2019, hit $235 in 2019, then crashed to $6 by 2024. Revenue peaked in 2021 and has declined every year since. Turns out plant-based meat is a niche product, not a mass-market replacement. They're burning cash, cutting staff, and searching for a turnaround strategy that doesn't exist.

Get smarter about NatureTech

Join 9,000+ founders, investors, and operators. Every week: the deals, the data, and the analysis you won't find anywhere else. Subscribe free

Reply

Avatar

or to participate

Keep Reading